 |
News
Newly identified natural protein blocks HIV, other deadly viruses
A team of UCLA-led researchers has identified a protein with broad virus-fighting properties that potentially could be used as a weapon against deadly human pathogenic viruses such as HIV, Ebola, Rift Valley Fever, Nipah and others designated "priority pathogens" for national biosecurity purposes by the National Institute of Allergy and Infectious Disease.
In a study published in the January issue of the journal Immunity, the researchers describe the novel antiviral property of the protein, cholesterol-25-hydroxylase (CH25H), an enzyme that converts cholesterol to an oxysterol called 25-hydroxycholesterol (25HC), which can permeate a cell's wall and block a virus from getting in. Read more »
Other News
- Researchers identify possible key to slow progression toward AIDS
- UCLA-led project aimed at African American couples affected by HIV gets $2.5M boost
- Drug combo much better than AZT alone at preventing mother-to-infant HIV transmission
- UCLA launches novel matching program for HIV/AIDS study volunteers
- UCLA-engineered stem cells seek out and kill HIV in living organisms
- UCLA researchers suggest unconventional approach to control HIV epidemics
- Early trial suggests rectal microbicide is safe, could significantly reduce HIV transmission
- Clinical trial uncovers potential 'functional cure' for HIV/AIDS
- Tenofovir gel protects rectal tissue against HIV, UCLA-led study finds
- UCLA partnership receives $12 million grant to improve HIV care in Malawi
- UCLA researchers demonstrate that stem cells can be engineered to kill HIV
- UCLA AIDS Institute director awarded $20 million state grant to fund translational work
- Circumcision rates lower in states where Medicaid does not cover procedure
- UCLA researchers demonstrate that stem cells can be engineered to kill HIV
